With the race for COVID-19 treatments and a vaccine well under way, the issue of drug pricing is again front and center, BioPharm International reports.
As uncertainty swirls around Pfizer and AstraZeneca's pledge to offer COVID-19 treatments at no profit, according to the report, some legislators are pushing for free vaccinations.
To read more on BioPharm International, click here.
